Bilayer Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

Bilayer Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $300,000 sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Bilayer Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2020

SEC CIK1859506

What does Bilayer Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $300,000 sold (2023).

Frequently asked questions about Bilayer Therapeutics

Where is Bilayer Therapeutics headquartered?

Bilayer Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Bilayer Therapeutics do?

Bilayer Therapeutics, Inc. is a biotechnology company.

When was Bilayer Therapeutics founded?

The earliest incorporation on record for Bilayer Therapeutics, Inc. is in 2020, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences